**Question:** A 25 year old overweight female was given fentanyl-pancuronium anaesthesia for surgery. After surgery and extubation she was observed to have limited movement of the upper body and chest wall in the recovery room. She was conscious and alert but voluntary respiratory effort has limited. Her blood pressure and heart rate were normal. The likely diagnosis is –

A. Hypotension
B. Bradycardia
C. Respiratory muscle paralysis
D. Tachycardia

**Correct Answer:** C. Respiratory muscle paralysis

**Core Concept:** Pancuronium is a non-depolarizing neuromuscular blocking agent that works by blocking the acetylcholine receptors at the neuromuscular junction, leading to a temporary paralysis of the skeletal muscles including those responsible for breathing. This is a key feature of pancuronium's pharmacological action and is essential for maintaining a stable and controlled surgical environment.

**Why the Correct Answer is Right:** The clinical scenario describes a patient who received pancuronium during surgery and experienced limited movement of her upper body and chest wall in the recovery room. This is consistent with pancuronium's pharmacological action of blocking neuromuscular transmission, leading to muscle paralysis. In this case, the paralysis affects the respiratory muscles, resulting in limited voluntary respiratory effort. The patient's normal blood pressure and heart rate further support that the issue is primarily with muscle function.

**Why Each Wrong Option is Incorrect:**

A. Hypotension: The patient's normal blood pressure indicates that hypotension is not the cause of the respiratory muscle paralysis.
B. Bradycardia: The patient's normal heart rate further supports that the issue is not primarily related to cardiovascular function.
D. Tachycardia: Like option A, the patient's normal heart rate indicates that tachycardia is not the cause of the respiratory muscle paralysis.

**Clinical Pearls:**

1. Neuromuscular blocking agents, like pancuronium, are commonly used in surgery to ensure a stable operating environment and reduce the risk of coughing, laryngospasm, or other involuntary movements that may interfere with the procedure.
2. The paralysis caused by pancuronium is typically temporary and reversible, allowing the patient to recover their motor function after discontinuation of the medication.
3. In this case, the patient's respiratory muscle paralysis is a direct consequence of pancuronium administration, which may lead to complications such as respiratory distress, hypoxia, and potential respiratory failure if not promptly addressed. This emphasizes the importance of monitoring patients closely during anesthesia and ensuring adequate ventilation post-surgery.